期刊文献+

他汀类药物对冠心病血管重建治疗的影响

下载PDF
导出
摘要 冠心病血管重建治疗包括经皮冠状动脉腔内成形术(PTCA)和冠状动脉旁路移植术(CABG).近20年来,这两项技术均迅速发展,成为冠心病血管重建治疗的重要手段.与此同时,他汀类药物降脂治疗在冠心病一级和二级预防中发挥了重要作用,是近年来冠心病治疗学发展的里程碑之一.有关他汀类药物对冠心病血管重建治疗的影响,主要从三方面进行探讨.其一是长期的他汀类药物治疗是否能减少冠心病患者需要接受血管重建术的可能;其二是他汀类药物与血管重建术治疗冠心病的疗效比较;其三是他汀类药物与血管重建治疗联合应用在冠心病防治中的地位.
作者 赵水平
出处 《中南药学》 CAS 2003年第5期259-261,共3页 Central South Pharmacy
  • 相关文献

参考文献12

  • 1[1]Shepherd J,Cobbe SM,Ford I,et al Prevention of coronary heart disease with pravastin in men with hypercholeterolemia[J] N Engl J Med,1995,333(20):1301
  • 2[2]Downs JR, Clearfield M, Wies S,et al Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCaps Air Force/Texas Coronary Atherosclerosis Prevention Study[J] JAMA, 1998,299(20):1615
  • 3[3]The Scandinavian Simvastatin Survival Study Group.Randomised trial of lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344(8934):1383
  • 4[4]Sacks FM, Pfeffer MA, Moye LA,et al The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels[J] N Engl J Med,1996,335(14):1001
  • 5[5]The Long-Term Intervention with Pravastatin in ischaemic disease(LIPID)study group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial choleesterol levels[J] N Engl J Med,1998,339(19):1349
  • 6[6]Pitt B,Waters D,Brown WV,et al Aggressive-lipid lowering therapy compared with angioplasty in stable coronary artery disease Atorvastatin versus Revascularization Treatment Investigator[J] N Engl J Med,1999,341(2):70
  • 7[7]Blumenthal RS, Cohn G, Schuman SP Medical therapy versus coronary angioplasty in stable coronary artery disease A Critical review of the literature[J] J Am Coll Cardiol,2000,36(3):668
  • 8[8]Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous vein coronary-artery bypass grafts[J] N Engl J Med,1997,336(3):153
  • 9[9]Knatterud GL,Rosenberg Y,Campeau L,et al Long term effects on clinical outcomes of aggressive lowering of low density lipoprotein cholesteol levels and low dose anticoagulation in the post coronary artery bypass graft trial[J] Circulation, 2000,102(2):157
  • 10[10]White CW, Gobel FL, Campeau L,et al The effect of an aggressive lipid lowering strategy on the progression of atherosclerosis in the left main coronary artery from patients in the Post Coronary Artery Bypass Graft Trial[J] Circulation,2001,104(22):2660

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部